WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 23, 2013

Primary Completion Date

September 25, 2016

Study Completion Date

September 25, 2016

Conditions
Refractory Anastomotic Esophageal Strictures
Interventions
DEVICE

WallFlex Esophageal RX Fully Covered Stent

Temporary placement of the WallFlex Esophageal RX Fully Covered Stent for treatment of refractory anastomotic esophageal strictures. The stent will be removed after 8 weeks (plus or minus 7 days) indwell

DEVICE

Esophageal Bougie Dilator Per Investigator preference

Commercially available Esophageal Bougie Dilator Per Investigator preference

Trial Locations (4)

3015

Erasmus Medical Center, Rotterdam

05612-000

Instituto do Cancer do Estado de Sao Paulo, São Paulo

1105 AZ

Academisch Medisch Centrum, Amsterdam

S-14186

Karolinska Universitets Sjukhuset, Stockholm

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT01699542 - WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture | Biotech Hunter | Biotech Hunter